| CASE REPORT |
|
| Year : 2019 | Volume
: 18
| Issue : 4 | Page : 206-209 |
|
|
Development of crohn's disease following treatment for juvenile idiopathic arthritis in a nigerian child: Case report and review of literature
Oluwafunmilayo Funke Adeniyi1, Uyi Ima-Edomwonyi2, A Emuobor Odeghe3, I Vincent Onyekwelu4
1 Department of Paediatrics, Paediatric Gastroenterology Unit, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria
2 Department of Internal Medicine, Lagos University Teaching Hospital, Lagos, Nigeria
3 Department of Internal Medicine, Gastroenterology Unit, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria
4 Department of Histopathology, Clina Lancet Laboratories, Lagos, Nigeria
Correspondence Address:
Dr. Oluwafunmilayo Funke Adeniyi
Departments of Paediatrics, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Idi - Araba, Lagos
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/aam.aam_16_19
|
|
|
Juvenile idiopathic arthritis (JIA) and Crohn's disease (CD) are diseases that are rarely seen in the black African child. CD has been reported to occur following therapy with etanercept in JIA patients. We report the case of a Nigerian child with JIA who developed CD following treatment for JIA. A 9-year-old male with JIA was referred to the pediatric gastroenterology unit of the Lagos University Teaching Hospital on the account of chronic diarrhea with occasional passage of bloody stools. He had been on prednisolone and methotrexate which had controlled the joint flares. Colonoscopy revealed extensive colitis, ulcers, abscesses, and ileocecal disease. Histology confirmed the CD. In view of the unavailability of the recommended treatment, namely biologics in the country and financial constraints; steroids; and sulfasalazine were added to his treatment regimen, and subsequently, he has made significant clinical improvement.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
